Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-22-000004

Director acquired 1,150 shares (grant or award)

  • Director acquired 712 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anderson Kenneth Carl Director 2022-10-03 Option exercise +267 $2.11 $563 91,253 D
Anderson Kenneth Carl Director 2022-10-03 Option exercise +445 $4.98 $2,216 91,698 D
Anderson Kenneth Carl Director 2022-10-03 Grant or award +1,150 $8.69 $9,994 92,848 D
Derivatives
Anderson Kenneth Carl Director 2022-10-03 Option exercise · Stock Option (Right to Buy) −267 1,335 D
Anderson Kenneth Carl Director 2022-10-03 Option exercise · Stock Option (Right to Buy) −445 1,334 D
Loading xslF345X03/wf-form4_166492110095346.xml…